Washington - The FDA advisory panel reviewing Hylaform and Restylane, the newest upstarts in the battle against wrinkles and scars, recommended each for approval, with conditions, by a 6-3 vote November 21.
LC-OCT Demonstrates Non-Invasive Evaluation Capabilities of Dermal Fillers
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Hair-Raising Challenges
The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
FDA Clears Candela's Matrix Radiofrequency Platform for Treatment of Facial Wrinkles
Insights Into Positive Decision for Galderma's RelabotulinumtoxinA in Europe